Home / Recalls / Medical Devices
Phadia US Inc recalls ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative as
Recalled April 11, 2018 · FDA recall Z-1312-2018 · Phadia US
Hazard
The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met. · FDA Class II
Units
950 total
Sold at
Nationwide Distribution
Description
The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.
Product
ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. To be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.
Manufacturer(s)
Phadia US Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →